3. Active Pharmaceutical Ingredients (APIs)

Extensive portfolio across major therapeutic areas from R&D to commercial scale:

• Cardiometabolic (Core Strength): Valsartan, Telmisartan, Irbesartan, Amlodipine, Apixaban, Rivaroxaban, Sacubitril, Empagliflozin, Linagliptin.
• Central Nervous System (CNS): Pregabalin, Gabapentin, Levetiracetam, Donepezil HCl, Vortioxetine HBr, Sertraline, Aripiprazole, Quetiapine Fumarate.
• Specialty & High-Potency APIs: Ruxolitinib, Voriconazole, Tofacitinib Citrate, Upadacitinib (Amorphous/Hemihydrate), Baricitinib (Amorphous/Form I), Semaglutide (under development).
• Key Supplier: Huahai Pharma (with USDMF, CEP, EDMF filings). Comprehensive polymorphism and flow chemistry expertise.